Literature DB >> 24388550

Uric acid, chronic kidney disease and type 2 diabetes: a cluster of vascular risk factors.

Vasilios G Athyros1, Dimitri P Mikhailidis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24388550     DOI： 10.1016/j.jdiacomp.2013.11.012

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN： 1056-8727            Impact factor:   2.852


× No keyword cloud information.
  5 in total

Review 1.  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Niki Katsiki; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

2.  Treatment of Inflammatory Diseases with IL-1 Blockade.

Authors:  Charles A Dinarello
Journal:  Curr Otorhinolaryngol Rep       Date:  2018-03-07

3.  Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway.

Authors:  Tania O Crişan; Maartje C P Cleophas; Boris Novakovic; Kathrin Erler; Frank L van de Veerdonk; Hendrik G Stunnenberg; Mihai G Netea; Charles A Dinarello; Leo A B Joosten
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

4.  Fingolimod Phosphate (FTY720-P) Activates Protein Phosphatase 2A in Human Monocytes and Inhibits Monosodium Urate Crystal-Induced Interleukin-1β Production.

Authors:  Marwa Qadri; Sandy ElSayed; Khaled A Elsaid
Journal:  J Pharmacol Exp Ther       Date:  2020-11-25       Impact factor: 4.030

5.  An Invert U-Shaped Curve: Relationship Between Fasting Plasma Glucose and Serum Uric Acid Concentration in a Large Health Check-Up Population in China.

Authors:  Haibo Li; Xiaojuan Zha; Yu Zhu; Mengxue Liu; Rui Guo; Yufeng Wen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.